Anandron (RU 23908) associated to surgical castration in previously untreated stage D prostate cancer: a multicenter comparative study of two doses of the drug and of a placebo

Authors :: J M, Brisset
L, Boccon-Gibod
H, Botto
M, Camey
G, Cariou
J M, Duclos
F, Duval
D, Gontiès
R, Jorest
L, Lamy
Source :: Progress in clinical and biological research.
Publication Year :: 1987

Subjects :: Male
Clinical Trials as Topic
Imidazoles
Humans
Prostatic Neoplasms
Androgen Antagonists
Imidazolidines
Combined Modality Therapy
Orchiectomy
Aged

Tools